Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Apollo Hospitals EnterpriseBOM:508869 -0.99%94 3-Year ROIIC % is 13.99 as of Mar. 2026, which is 3% below its 10-year median of 14.44. GuruFocus rates BOM:508869 with a GF Score™ of 94/100 and a GF Value™ of ₹9,113.82 (Fairly Valued). The stock has 3 warning signs investors should review. Among 619 Healthcare Providers & Services companies, Apollo Hospitals Enterprise ranks better than 68.34% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Apollo Hospitals Enterprise's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 13.99%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Apollo Hospitals Enterprise's 3-Year ROIIC % or its related term are showing as below:
BOM:508869's 3-Year ROIIC % is ranked better than 68.34% of 619
companies
in the Healthcare Providers & Services industry
Industry Median: 3.66
vs BOM:508869: 13.99
Apollo Hospitals Enterprise (BOM:508869) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Apollo Hospitals Enterprise 3-Year ROIIC % Related Terms
Apollo Hospitals Enterprise 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:508869 vs HCA, THC, DVA: 3-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, Apollo Hospitals Enterprise's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apollo Hospitals Enterprise 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Apollo Hospitals Enterprise's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Apollo Hospitals Enterprise's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Apollo Hospitals Enterprise (BOM:508869) has a 3-Year ROIIC % of 13.99 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Apollo Hospitals Enterprise and its competitors. This is near median its historical median of 14.44. According to the industry distribution chart, Apollo Hospitals Enterprise ranks #196 out of 619 companies in the Healthcare Providers & Services industry, placing it in the top 31.7%.
Is Apollo Hospitals Enterprise's 3-Year ROIIC % too high?
Apollo Hospitals Enterprise's current 3-Year ROIIC % of 13.99 is near median its 10-year median of 14.44. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.66. Apollo Hospitals Enterprise's value of 13.99 is 282.2% above this industry median. Based on the distribution chart, Apollo Hospitals Enterprise ranks #196 out of 619 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Apollo Hospitals Enterprise has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Apollo Hospitals Enterprise's 3-Year ROIIC % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Apollo Hospitals Enterprise ranks #196 out of 619 companies for 3-Year ROIIC %. This puts Apollo Hospitals Enterprise in the upper half of its industry. The industry median 3-Year ROIIC % is 3.66. Apollo Hospitals Enterprise's value of 13.99 is 282.2% above this benchmark. While the company's 10-year median is 14.44 vs. the industry median of 3.66, Apollo Hospitals Enterprise has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.66, based on 619 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apollo Hospitals Enterprise's current 3-Year ROIIC % of 13.99 is 282.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Apollo Hospitals Enterprise and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apollo Hospitals Enterprise's current 3-Year ROIIC % is 13.99, which is near median its own 10-year median of 14.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apollo Hospitals Enterprise stock overvalued right now?
Based on GuruFocus' analysis, Apollo Hospitals Enterprise (BOM:508869) is currently considered Fairly Valued. The stock's GF Value™ is ₹9,113.82, compared to a current price of ₹8,790.00 — trading 3.6% below its estimated fair value. The current 3-Year ROIIC % is 13.99, which is near median its 10-year median of 14.44 and 282.2% above the Healthcare Providers & Services industry median of 3.66. Apollo Hospitals Enterprise's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Apollo Hospitals Enterprise (BOM:508869), the current 3-Year ROIIC % is 13.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apollo Hospitals Enterprise (BOM:508869) Overvalued in 2026?
Based on GuruFocus' analysis, Apollo Hospitals Enterprise stock appears to be undervalued.
The current stock price of ₹8,790.00 is trading 3.6% below its estimated GF Value™ of ₹9,113.82.
GuruFocus considers Apollo Hospitals Enterprise to be Fairly Valued.
Key valuation signals for BOM:508869:
3-Year ROIIC %: 13.99 (near median its 10-year median of 14.44)
GF Value™: ₹9,113.82 vs. price of ₹8,790.00 (3.6% below fair value)
Industry Position: 282.2% above the Healthcare Providers & Services median (#196 of 619)
No single metric tells the full story. See the BOM:508869 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. Its reportable operating segments are; Healthcare Services (represents hospitals and hospitals services); Retail Health and Diagnostics (includes clinics and diagnostics); Digital Health and Pharmacy Distribution; and Others. Maximum revenue is generated from its Healthcare Services segment.
94GF Score
Get the complete analysis for BOM:508869
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:508869 has been successfully added to your 
